Mi19 (R), n=5 cell(s)

Main group: Optic Neuropil Intrinsic Neurons; Neurotransmitter consensus prediction: 5HT

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 923.8 198.4 57.2 25.2 4.6 14.4 246.8 555.8 362.4 69.8 2458.4
1 988.8 171.4 19.8 5.0 0.4 1.0 19.6 69.4 50.2 12.0 1337.6
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - - -
Pre - - - - - - - -
  AME
0 4.8
1 2.0
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 -
1 -

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses:12292
Number of pre synapses:6688
Number of output connections:14614
Coverage factor:2.5
Columnar completeness:1.00
Area completeness:1.00
Cell size (columns):413

Lobula

Number of post synapses:0
Number of pre synapses:0
Number of output connections:0
Coverage factor:0
Columnar completeness:0
Area completeness:0
Cell size (columns):0

Lobula Plate

Number of post synapses:0
Number of pre synapses:0
Number of output connections:0
Coverage factor:0
Columnar completeness:0
Area completeness:0
Cell size (columns):0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#Mi19 (R) % % cumu.
0 Pm3 (R) GABA 1,637 327.4 13.5% 13.5%
1 Tm3 (R) ACh 1,574 314.8 13.0% 26.4%
2 Mi10 (R) ACh 952 190.4 7.8% 34.3%
3 MeVC25 (R) Glu 760 152.0 6.3% 40.6%
4 MeVC3 (L) ACh 690 138.0 5.7% 46.2%
5 MeVC23 (R) Glu 573 114.6 4.7% 51.0%
6 TmY5a (R) Glu 435 87.0 3.6% 54.5%
7 MeVPMe12 (L) ACh 425 85.0 3.5% 58.0%
8 MeVC11 (L) ACh 392 78.4 3.2% 61.3%
9 Cm34 (R) Glu 272 54.4 2.2% 63.5%
10 L5 (R) ACh 230 46.0 1.9% 65.4%
11 Mi1 (R) ACh 224 44.8 1.8% 67.2%
12 Tm6 (R) ACh 213 42.6 1.8% 69.0%
13 Dm16 (R) Glu 210 42.0 1.7% 70.7%
14 Tm5c (R) Glu 206 41.2 1.7% 72.4%
15 OA-AL2i3 (R) OA 180 36.0 1.5% 73.9%
16 aMe17e (R) Glu 157 31.4 1.3% 75.2%
17 T2 (R) ACh 147 29.4 1.2% 76.4%
18 Dm18 (R) GABA 142 28.4 1.2% 77.6%
19 Mi15 (R) ACh 139 27.8 1.1% 78.7%
20 OLVC5 (R) ACh 136 27.2 1.1% 79.9%
21 Mi13 (R) Glu 129 25.8 1.1% 80.9%
22 LPT54 (R) ACh 125 25.0 1.0% 81.9%
23 MeLo1 (R) ACh 100 20.0 0.8% 82.8%
24 TmY19a (R) GABA 99 19.8 0.8% 83.6%
25 MeVPMe12 (R) ACh 96 19.2 0.8% 84.4%
26 Tm4 (R) ACh 78 15.6 0.6% 85.0%
27 Mi14 (R) Glu 75 15.0 0.6% 85.6%
28 MeVPMe1 (L) Glu 67 13.4 0.6% 86.2%
29 MeVPMe1 (R) Glu 67 13.4 0.6% 86.7%
30 L4 (R) ACh 61 12.2 0.5% 87.2%
31 Mi2 (R) Glu 60 12.0 0.5% 87.7%
32 Dm1 (R) Glu 53 10.6 0.4% 88.2%
33 MeLo9 (R) Glu 50 10.0 0.4% 88.6%
34 MeVPMe2 (L) Glu 47 9.4 0.4% 89.0%
35 Dm10 (R) GABA 44 8.8 0.4% 89.3%
36 MeVCMe1 (R) ACh 42 8.4 0.3% 89.7%
37 Pm1 (R) GABA 42 8.4 0.3% 90.0%
38 Tm2 (R) ACh 37 7.4 0.3% 90.3%
39 MeLo7 (R) ACh 34 6.8 0.3% 90.6%
40 Dm17 (R) Glu 33 6.6 0.3% 90.9%
41 T4b (R) ACh 32 6.4 0.3% 91.1%
42 TmY15 (R) GABA 32 6.4 0.3% 91.4%
43 PVLP046 (L) GABA 30 6.0 0.2% 91.7%
44 TmY19b (R) GABA 29 5.8 0.2% 91.9%
45 TmY18 (R) ACh 27 5.4 0.2% 92.1%
46 Y3 (R) ACh 27 5.4 0.2% 92.3%
47 MeLo8 (R) GABA 26 5.2 0.2% 92.6%
48 Mi19 (R) 5HT 24 4.8 0.2% 92.8%
49 Mi4 (R) GABA 21 4.2 0.2% 92.9%
50 PVLP046 (R) GABA 21 4.2 0.2% 93.1%
51 aMe4 (R) ACh 20 4.0 0.2% 93.3%
52 Cm8 (R) GABA 20 4.0 0.2% 93.4%
53 Pm8 (R) GABA 20 4.0 0.2% 93.6%
54 Pm9 (R) GABA 20 4.0 0.2% 93.8%
55 C3 (R) GABA 19 3.8 0.2% 93.9%
56 T3 (R) ACh 19 3.8 0.2% 94.1%
57 MeVCMe1 (L) ACh 18 3.6 0.1% 94.2%
58 Tm37 (R) Glu 18 3.6 0.1% 94.4%
59 T2a (R) ACh 16 3.2 0.1% 94.5%
60 TmY3 (R) ACh 16 3.2 0.1% 94.6%
61 Dm6 (R) Glu 15 3.0 0.1% 94.8%
62 MeLo3a (R) ACh 15 3.0 0.1% 94.9%
63 MeVC1 (L) ACh 15 3.0 0.1% 95.0%
64 Pm10 (R) GABA 15 3.0 0.1% 95.1%
65 Tm1 (R) ACh 15 3.0 0.1% 95.2%
66 Dm14 (R) Glu 14 2.8 0.1% 95.4%
67 MeLo14 (R) Glu 14 2.8 0.1% 95.5%
68 Mi17 (R) GABA 14 2.8 0.1% 95.6%
69 Pm5 (R) GABA 14 2.8 0.1% 95.7%
70 OA-ASM1 (R) OA 13 2.6 0.1% 95.8%
71 aMe12 (R) ACh 12 2.4 0.1% 95.9%
72 C2 (R) GABA 12 2.4 0.1% 96.0%
73 Pm2a (R) GABA 12 2.4 0.1% 96.1%
74 Pm2b (R) GABA 12 2.4 0.1% 96.2%
75 Pm4 (R) GABA 12 2.4 0.1% 96.3%
76 l-LNv (R) unclear 11 2.2 0.1% 96.4%
77 Lawf2 (R) ACh 11 2.2 0.1% 96.5%
78 Dm19 (R) Glu 10 2.0 0.1% 96.6%
79 DNc02 (L) unclear 10 2.0 0.1% 96.7%
80 MeLo11 (R) Glu 10 2.0 0.1% 96.7%
81 MeVC4b (L) ACh 10 2.0 0.1% 96.8%
82 Tm20 (R) ACh 10 2.0 0.1% 96.9%
83 Tm26 (R) ACh 10 2.0 0.1% 97.0%
84 Cm21 (R) GABA 9 1.8 0.1% 97.1%
85 Dm9 (R) Glu 9 1.8 0.1% 97.1%
86 Lawf1 (R) ACh 9 1.8 0.1% 97.2%
87 MeLo10 (R) Glu 9 1.8 0.1% 97.3%
88 MeVC27 (L) unclear 9 1.8 0.1% 97.4%
89 MeVP3 (R) ACh 9 1.8 0.1% 97.4%
90 Mi18 (R) GABA 9 1.8 0.1% 97.5%
91 Cm16 (R) Glu 8 1.6 0.1% 97.6%
92 Cm7 (R) Glu 8 1.6 0.1% 97.6%
93 MeLo13 (R) Glu 8 1.6 0.1% 97.7%
94 MeVPMe2 (R) Glu 8 1.6 0.1% 97.8%
95 OA-ASM1 (L) OA 8 1.6 0.1% 97.8%
96 TmY14 (R) Glu 8 1.6 0.1% 97.9%
97 Cm6 (R) GABA 7 1.4 0.1% 98.0%
98 Dm15 (R) Glu 7 1.4 0.1% 98.0%
99 Dm20 (R) Glu 7 1.4 0.1% 98.1%
100 OA-AL2i2 (R) OA 7 1.4 0.1% 98.1%
101 TmY21 (R) ACh 7 1.4 0.1% 98.2%
102 DNc01 (L) unclear 6 1.2 0.0% 98.2%
103 L3 (R) ACh 6 1.2 0.0% 98.3%
104 Pm7 (R) GABA 6 1.2 0.0% 98.3%
105 TmY10 (R) ACh 6 1.2 0.0% 98.4%
106 TmY13 (R) ACh 6 1.2 0.0% 98.4%
107 Dm-DRA1 (R) Glu 5 1.0 0.0% 98.5%
108 L1 (R) Glu 5 1.0 0.0% 98.5%
109 MeVP4 (R) ACh 5 1.0 0.0% 98.6%
110 Mi9 (R) Glu 5 1.0 0.0% 98.6%
111 OLVC7 (L) Glu 5 1.0 0.0% 98.6%
112 Pm12 (R) Glu 5 1.0 0.0% 98.7%
113 Y14 (R) Glu 5 1.0 0.0% 98.7%

Outputs

  instance NT total connections connections /#Mi19 (R) % % cumu.
0 Dm18 (R) GABA 4,559 911.8 31.1% 31.1%
1 Tm6 (R) ACh 2,187 437.4 14.9% 46.0%
2 T2 (R) ACh 652 130.4 4.4% 50.4%
3 Tm3 (R) ACh 465 93.0 3.2% 53.6%
4 TmY5a (R) Glu 464 92.8 3.2% 56.7%
5 L5 (R) ACh 285 57.0 1.9% 58.7%
6 Mi1 (R) ACh 285 57.0 1.9% 60.6%
7 Mi14 (R) Glu 234 46.8 1.6% 62.2%
8 MeLo2 (R) ACh 225 45.0 1.5% 63.8%
9 Tm4 (R) ACh 218 43.6 1.5% 65.2%
10 Dm1 (R) Glu 214 42.8 1.5% 66.7%
11 Dm16 (R) Glu 205 41.0 1.4% 68.1%
12 Dm10 (R) GABA 196 39.2 1.3% 69.4%
13 Lawf2 (R) ACh 196 39.2 1.3% 70.8%
14 Mi4 (R) GABA 188 37.6 1.3% 72.1%
15 Tm5c (R) Glu 176 35.2 1.2% 73.3%
16 Lawf1 (R) ACh 171 34.2 1.2% 74.4%
17 OA-AL2i3 (R) OA 165 33.0 1.1% 75.5%
18 TmY3 (R) ACh 165 33.0 1.1% 76.7%
19 Dm17 (R) Glu 146 29.2 1.0% 77.7%
20 Mi15 (R) ACh 126 25.2 0.9% 78.5%
21 Mi2 (R) Glu 113 22.6 0.8% 79.3%
22 Dm14 (R) Glu 109 21.8 0.7% 80.0%
23 C3 (R) GABA 107 21.4 0.7% 80.8%
24 Mi13 (R) Glu 107 21.4 0.7% 81.5%
25 Dm6 (R) Glu 104 20.8 0.7% 82.2%
26 TmY18 (R) ACh 102 20.4 0.7% 82.9%
27 Tm12 (R) ACh 95 19.0 0.6% 83.5%
28 T2a (R) ACh 81 16.2 0.6% 84.1%
29 Pm1 (R) GABA 78 15.6 0.5% 84.6%
30 Tm2 (R) ACh 77 15.4 0.5% 85.2%
31 Mi18 (R) GABA 73 14.6 0.5% 85.6%
32 C2 (R) GABA 72 14.4 0.5% 86.1%
33 Mi10 (R) ACh 71 14.2 0.5% 86.6%
34 Tm20 (R) ACh 70 14.0 0.5% 87.1%
35 MeLo1 (R) ACh 68 13.6 0.5% 87.6%
36 Pm3 (R) GABA 65 13.0 0.4% 88.0%
37 Tm1 (R) ACh 61 12.2 0.4% 88.4%
38 Cm7 (R) Glu 53 10.6 0.4% 88.8%
39 Dm15 (R) Glu 51 10.2 0.3% 89.1%
40 MeLo9 (R) Glu 49 9.8 0.3% 89.5%
41 L2 (R) ACh 43 8.6 0.3% 89.8%
42 Dm19 (R) Glu 41 8.2 0.3% 90.0%
43 L1 (R) Glu 41 8.2 0.3% 90.3%
44 L4 (R) ACh 39 7.8 0.3% 90.6%
45 Dm3c (R) Glu 34 6.8 0.2% 90.8%
46 Pm4 (R) GABA 32 6.4 0.2% 91.0%
47 T3 (R) ACh 32 6.4 0.2% 91.2%
48 Dm3a (R) Glu 31 6.2 0.2% 91.5%
49 Tm37 (R) Glu 31 6.2 0.2% 91.7%
50 Dm9 (R) Glu 30 6.0 0.2% 91.9%
51 MeVC23 (R) Glu 30 6.0 0.2% 92.1%
52 Mi9 (R) Glu 30 6.0 0.2% 92.3%
53 Dm20 (R) Glu 28 5.6 0.2% 92.5%
54 Pm2a (R) GABA 28 5.6 0.2% 92.7%
55 TmY16 (R) Glu 27 5.4 0.2% 92.9%
56 Y14 (R) Glu 26 5.2 0.2% 93.0%
57 Mi19 (R) 5HT 24 4.8 0.2% 93.2%
58 Pm10 (R) GABA 23 4.6 0.2% 93.3%
59 Pm2b (R) GABA 23 4.6 0.2% 93.5%
60 MeLo8 (R) GABA 22 4.4 0.1% 93.7%
61 Y3 (R) ACh 21 4.2 0.1% 93.8%
62 MeLo13 (R) Glu 20 4.0 0.1% 93.9%
63 Pm7 (R) GABA 20 4.0 0.1% 94.1%
64 TmY9a (R) ACh 20 4.0 0.1% 94.2%
65 MeVCMe1 (R) ACh 19 3.8 0.1% 94.3%
66 MeVP51 (R) Glu 19 3.8 0.1% 94.5%
67 aMe4 (R) ACh 18 3.6 0.1% 94.6%
68 MeVPMe12 (L) ACh 18 3.6 0.1% 94.7%
69 Tm9 (R) ACh 18 3.6 0.1% 94.8%
70 TmY21 (R) ACh 18 3.6 0.1% 95.0%
71 MeVC25 (R) Glu 17 3.4 0.1% 95.1%
72 T1 (R) unclear 17 3.4 0.1% 95.2%
73 TmY10 (R) ACh 17 3.4 0.1% 95.3%
74 Dm2 (R) ACh 16 3.2 0.1% 95.4%
75 Tm16 (R) ACh 16 3.2 0.1% 95.5%
76 TmY15 (R) GABA 16 3.2 0.1% 95.6%
77 Dm12 (R) Glu 15 3.0 0.1% 95.7%
78 MeLo10 (R) Glu 15 3.0 0.1% 95.8%
79 Pm5 (R) GABA 15 3.0 0.1% 95.9%
80 TmY14 (R) Glu 15 3.0 0.1% 96.0%
81 Dm3b (R) Glu 14 2.8 0.1% 96.1%
82 MeVCMe1 (L) ACh 14 2.8 0.1% 96.2%
83 Tm5Y (R) ACh 14 2.8 0.1% 96.3%
84 MeLo7 (R) ACh 13 2.6 0.1% 96.4%
85 MeVPMe12 (R) ACh 13 2.6 0.1% 96.5%
86 Pm9 (R) GABA 13 2.6 0.1% 96.6%
87 TmY13 (R) ACh 13 2.6 0.1% 96.7%
88 Pm8 (R) GABA 12 2.4 0.1% 96.8%
89 MeVC11 (L) ACh 11 2.2 0.1% 96.8%
90 MeVPLo1 (R) Glu 11 2.2 0.1% 96.9%
91 MeVPMe1 (L) Glu 10 2.0 0.1% 97.0%
92 TmY19a (R) GABA 10 2.0 0.1% 97.0%
93 MeVPMe1 (R) Glu 9 1.8 0.1% 97.1%
94 Mi16 (R) GABA 9 1.8 0.1% 97.2%
95 Pm12 (R) Glu 9 1.8 0.1% 97.2%
96 Tm36 (R) ACh 9 1.8 0.1% 97.3%
97 TmY9b (R) ACh 9 1.8 0.1% 97.4%
98 Cm34 (R) Glu 8 1.6 0.1% 97.4%
99 Cm8 (R) GABA 8 1.6 0.1% 97.5%
100 MeVP4 (R) ACh 8 1.6 0.1% 97.5%
101 MeVPMe2 (R) Glu 8 1.6 0.1% 97.6%
102 Tm5b (R) ACh 8 1.6 0.1% 97.6%
103 TmY4 (R) ACh 8 1.6 0.1% 97.7%
104 LPT54 (R) ACh 7 1.4 0.0% 97.7%
105 MeVC1 (L) ACh 7 1.4 0.0% 97.8%
106 MeVC3 (L) ACh 7 1.4 0.0% 97.8%
107 MeVP18 (R) unclear 7 1.4 0.0% 97.9%
108 Pm11 (R) GABA 7 1.4 0.0% 97.9%
109 Tm39 (R) ACh 7 1.4 0.0% 98.0%
110 Y13 (R) Glu 7 1.4 0.0% 98.0%
111 aMe17e (R) Glu 6 1.2 0.0% 98.1%
112 aMe3 (R) Glu 6 1.2 0.0% 98.1%
113 Cm13 (R) Glu 6 1.2 0.0% 98.1%
114 Cm2 (R) ACh 6 1.2 0.0% 98.2%
115 MeLo3b (R) ACh 6 1.2 0.0% 98.2%
116 MeVP3 (R) ACh 6 1.2 0.0% 98.3%
117 Tm5a (R) ACh 6 1.2 0.0% 98.3%
118 TmY19b (R) GABA 6 1.2 0.0% 98.3%
119 aMe30 (R) Glu 5 1.0 0.0% 98.4%
120 Cm3 (R) GABA 5 1.0 0.0% 98.4%
121 Cm5 (R) GABA 5 1.0 0.0% 98.4%
122 Dm8a (R) Glu 5 1.0 0.0% 98.5%
123 l-LNv (L) unclear 5 1.0 0.0% 98.5%
124 Pm13 (R) Glu 5 1.0 0.0% 98.5%
125 Pm6 (R) GABA 5 1.0 0.0% 98.6%
126 T4d (R) ACh 5 1.0 0.0% 98.6%
127 Tm38 (R) ACh 5 1.0 0.0% 98.7%